242 related articles for article (PubMed ID: 34302663)
21. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
[TBL] [Abstract][Full Text] [Related]
22. Optimization of the production of knock-in alleles by CRISPR/Cas9 microinjection into the mouse zygote.
Raveux A; Vandormael-Pournin S; Cohen-Tannoudji M
Sci Rep; 2017 Feb; 7():42661. PubMed ID: 28209967
[TBL] [Abstract][Full Text] [Related]
23. Gene Disruption Using CRISPR-Cas9 Technology.
Hu N; Malek SN
Methods Mol Biol; 2019; 1881():201-209. PubMed ID: 30350208
[TBL] [Abstract][Full Text] [Related]
24. Precision genome editing in the CRISPR era.
Salsman J; Dellaire G
Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
[TBL] [Abstract][Full Text] [Related]
25. Creation of zebrafish knock-in reporter lines in the nefma gene by Cas9-mediated homologous recombination.
Eschstruth A; Schneider-Maunoury S; Giudicelli F
Genesis; 2020 Jan; 58(1):e23340. PubMed ID: 31571409
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs.
Petazzi P; Menéndez P; Sevilla A
Methods Mol Biol; 2022; 2454():559-574. PubMed ID: 33190185
[TBL] [Abstract][Full Text] [Related]
27. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
[TBL] [Abstract][Full Text] [Related]
28. Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans.
Paix A; Folkmann A; Seydoux G
Methods; 2017 May; 121-122():86-93. PubMed ID: 28392263
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
Santos DP; Kiskinis E; Eggan K; Merkle FT
Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
[TBL] [Abstract][Full Text] [Related]
30. Efficient bi-allelic tagging in human induced pluripotent stem cells using CRISPR.
Ren X; Takagi MA; Shen Y
STAR Protoc; 2023 Mar; 4(1):102084. PubMed ID: 36853689
[TBL] [Abstract][Full Text] [Related]
31. Increasing Gene Editing Efficiency for CRISPR-Cas9 by Small RNAs in Pluripotent Stem Cells.
Shahryari A; Moya N; Siehler J; Wang X; Burtscher I; Lickert H
CRISPR J; 2021 Aug; 4(4):491-501. PubMed ID: 34406042
[TBL] [Abstract][Full Text] [Related]
32. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
33. An optimized electroporation approach for efficient CRISPR/Cas9 genome editing in murine zygotes.
Tröder SE; Ebert LK; Butt L; Assenmacher S; Schermer B; Zevnik B
PLoS One; 2018; 13(5):e0196891. PubMed ID: 29723268
[TBL] [Abstract][Full Text] [Related]
34. CRISPR/Cas9 mediated GFP-human dentin matrix protein 1 (DMP1) promoter knock-in at the ROSA26 locus in mesenchymal stem cell for monitoring osteoblast differentiation.
Shahabipour F; Oskuee RK; Shokrgozar MA; Naderi-Meshkin H; Goshayeshi L; Bonakdar S
J Gene Med; 2020 Dec; 22(12):e3288. PubMed ID: 33047833
[TBL] [Abstract][Full Text] [Related]
35. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
36. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins.
Quadros RM; Miura H; Harms DW; Akatsuka H; Sato T; Aida T; Redder R; Richardson GP; Inagaki Y; Sakai D; Buckley SM; Seshacharyulu P; Batra SK; Behlke MA; Zeiner SA; Jacobi AM; Izu Y; Thoreson WB; Urness LD; Mansour SL; Ohtsuka M; Gurumurthy CB
Genome Biol; 2017 May; 18(1):92. PubMed ID: 28511701
[TBL] [Abstract][Full Text] [Related]
37. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9-Directed Genome Editing of Cultured Cells.
Yang L; Yang JL; Byrne S; Pan J; Church GM
Curr Protoc Mol Biol; 2014 Jul; 107():31.1.1-31.1.17. PubMed ID: 24984853
[TBL] [Abstract][Full Text] [Related]
39. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
40. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
Li GL; Yang SX; Wu ZF; Zhang XW
Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]